Waters Corporation Reports Strong 2024 Financial Results and Provides 2025 Guidance

Details

The company reported fourth-quarter sales of $873 million, up 6% as reported, and full-year sales of $2,958 million, flat as reported. GAAP EPS for the quarter was $3.88 and for the full year was $10.71. Non-GAAP EPS for the quarter was $4.10 and for the full year was $11.86. The company also provided guidance for 2025, expecting constant currency sales growth between 4.5% and 7.0%, with full-year non-GAAP EPS in the range of $12.70 to $13.00.

Items reported

Exhibits (1)

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.